InvestorsHub Logo
Followers 15
Posts 1158
Boards Moderated 0
Alias Born 12/21/2010

Re: TekNuLoof post# 318667

Thursday, 11/16/2017 9:54:01 AM

Thursday, November 16, 2017 9:54:01 AM

Post# of 346050
Criminals can't even get the article right. Shareholders money in the drain !


The firm is now looking to license to sell the candidate (along with the rest of its pipeline), a decision triggered by negative Phase III trial results announced in February this year.



Its failed in 2016 not this year.


Peregrine's lead candidate is bavituximab, a chimeric monoclonal antibody (mAb) under US Food and Drug Administration (FDA) fast-track designation for the treatment of second-line non-small cell lung cancer (NSCLC).



FTD is meaningless anymore since Sunrise failed.

Who are you kidding ? lets see who buys the failed drug from these criminals.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News